Drop-Ship Kits Today – Our Current GI-MAP Turnaround Time: 7–10 Business Days

Experience the Difference of AI-Powered DNA Testing with GenomicInsight

Diagnostic Solutions is pleased to offer clinicians the Genomic Insight® Genomic Health Profile powered by Opus23 Explorer. Unlike any other DNA test on the market, Genomic Insight® uses the most advanced artificial intelligence to allow clinicians unique insight into patient genomics. Using the Opus23® informatics platform, clinicians can now customize reports using an interactive dashboard that curates a patient’s genomic data in “real-time” by using the latest medical-literature databases and meta-data sets.

 GenomicINSIGHT - Powered by Opus23


GenomicInsight®reports on over 3,000 single nucleotide polymorphisms (SNPs) in one comprehensive functional DNA test. Online results include therapeutic recommendations backed by the latest medical literature from PubMed, GWAS (genome wide association study), dbSNP, HapMap (haplotype map) and several others.

Data gleaned from Genomic Insight® informatics uses the latest medical literature to provide relevant information on nutraceuticals, nutritional supplements, diet, and lifestyle interventions that can proactively influence a patient’s SNPs to reduce or prevent disease risk. Furthermore, pharmacogenomic results included in the profile allow practitioners to predict the efficacy of select pharmaceuticals tailored the individual’s genetic make-up.



Advancing Personalized Medicine Through Empowered DNA Testing

GenomicInsight® provides a global view of the interconnectedness of SNPs and offers access to informatics that reveal lifestyle and therapeutic recommendations that may influence a gene’s expression and function.

The role of genomics and epigenetics is recognized as an important tool in monitoring, preventing, and treating dysfunction. Furthermore, medical literature supports that epigenetics (the impact of the environment on gene expression) plays a critical role in human health.1

GenomicInsight® with Opus23 Explorer identifies how the function or dysfunction of one gene impacts the expression and function of a separately-related gene or SNP.

GenomicINSIGHT® evaluates every area of patient health.



GenomicInsight® Evaluates Over 12 Key Areas of Health

Including but not limited to:

• Methylation
• Detoxification
• Cognition
• Inflammation
• Anti-Aging
• Endocrine
• Structural
• Energy/Metabolism
• Estrogen Genomics
• Androgen Genomics
• Cardiometabolic
• Gastrointestinal



The GenomicInsight® DNA Testing Advantage

Genomic Insight® provides patients with next-level precision medicine. Results allow for:

  • Customizable, real-time informatics that can evaluate one area of health or many in one test
  • Universal SNP analysis using a simple saliva collection without costly “add-on” panels
  • Data-driven insights into how a patient may respond to therapeutic or lifestyle changes
  • Constantly updating researched-based data powered by our Opus23 Explorer software


DNA Testing for Health Optimization

Research has shown that while some SNP’s may be beneficial to patient health, others carry significant health risks. GenomicInsight® equips you and your patients with the data analysis and knowledge needed to optimize health on an individual level. By taking into account each patient’s unique genomics, practitioners can be proactive in preventing illness before it begins, and even influence some diseases already in progress.


GenomicINSIGHT - The Science of Precision Medicine

The Science of Precision Medicine




Combining today’s most advanced DNA testing with the powerful Opus23 Explorer interface, GenomicInsight® provides access to the perfect combination of high-complexity DNA testing, science, and current research. Data curated from the customizable online report opens the door for clinicians to form powerful clinician/patient bonds that benefit from forward-thinking precision medicine.


Order Now



Understanding DNA Testing

What Are SNPs?

Single Nucleotide Polymorphism (SNPs)Although most of the genome is virtually identical from person to person, up to 9% of the genome can vary among individuals. This variation contributes to individual differences in both disease susceptibility and therapeutic responses. Single nucleotide polymorphisms, or SNPs (pronounced “snips”), are an important type of genomic variation.

SNPs only make up a tiny portion of the human genome (0.4%), but because the genome is so enormous, this equals over 12 million locations. The differences or variations at these SNP locations contribute to differentiating us and making us unique.


The Power of Epigenetics

While genes and SNPs themselves are virtually unchangeable, their impact on health can be influenced. The influence of environmental, lifestyle, and nutritional factors is referred to as epigenetics. Genomic Insight® DNA test results offer dynamic opportunities to alter genetic expression – proving that genes do not equal destiny.

Patients and clinicians can work together to implement lifestyle changes that can positively influence the impact of risk-carrying SNPs. These highly-personalized treatment interventions can improve patient outcomes and change lives.


DNA Testing Advances the Application of Precision Medicine

Many SNPs can influence the odds, or risk, a patient has of developing a specific health condition. When it comes to specific diseases or syndromes, most SNPs carry low risks. Low risk does not mean that a SNP is unworthy of attention, but rather that the findings must be interpreted as part of an integrated whole, including other SNP result findings that the GenomicInsight® panel identifies.

GenomicInsight® provides an unprecedented and comprehensive understanding of a patient’s SNP genomics, coupled with an explanation of each SNP, its potential impact on health, and interventions clinical research has shown will impact their expression.

The Genomic Insight® DNA test fosters meaningful conversations between clinicians and patients. Enjoy powerful clinician/patient bonds as you work together to optimize wellness.



Diagnostic Solutions Laboratory does not share any patient data with third parties for commercial use. Additionally, we will never disclose or share your Genetic Information or Self-Reported Health Status with insurance companies or employers.

The Genetic Information NonDiscrimination Act (GINA) was enacted in 2008 and protects you from being discriminated against by employers and health insurance companies as a result of your genetics. The GINA Act was created to protect your genetic health information, and to allow patients access to protected, personalized medicine.

Unless required by law, we will never release your genetic information or your Self-Reported Health Status to anyone without obtaining your explicit consent.


  1. Azam Moosavi and Ali Motevalizadeh Ardekani, “Role of Epigenetics in Biology and Human Diseases,” 2016, www.ncbi.nlm.nih.gov/pmc/articles/PMC5075137/ (accessed November 19, 2018).



Services provided are for laboratory testing only. No charge is incurred for ordering collection kits.



Product Status

GenomicINSIGHT - The Science of Precision Medicine

Order Now


 Learning GenomicInsight

GenomicINSIGHT - Video Playlist

We've put together a playlist of video tutorials for learning how to use GenomicInsight. Stay tuned as we populate the feed with new content!

Start watching here:

Video Playlist


Report Wizard

The sample reports below are reflective of single-focused curated results using the Report Wizard function found in GenomicInsight's Opus23 Explorer. Practitioners can select from up to three categories at a time to create additional syndrome-specific reports when using the Report Wizard.


View Sample Reports

Estrogen Genomics
Androgen Genomics

Please note: while these PDFs are static report captures, the live reports contain interactive features to drill down for more granular information.



Newsletter Sign-up

By submitting this form, you are consenting to receive marketing emails from: Diagnostic Solutions Laboratory. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.